https://www.eurekalert.org/news-releases/940751
News Release 20-Jan-2022
Peer-Reviewed Publication
Mayo Clinic
A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy ― and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells ― may mount an inadequate immune response to COVID-19 vaccination.
-----
No comments:
Post a Comment